Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

U.S. Supreme Court again nixes Bayer challenge to weedkiller suits

Stock Markets Jun 27, 2022 22:26
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
2/2 © Reuters. FILE PHOTO: A woman uses a Monsanto's Roundup weedkiller spray without glyphosate in a garden in Ercuis near Paris, France, May 6, 2018. REUTERS/Benoit Tessier 2/2

By Dietrich Knauth

(Reuters) -The U.S. Supreme Court on Monday rejected another Bayer AG (ETR:BAYGN) bid to dismiss litigation alleging that its Roundup weedkiller causes cancer as the German pharmaceutical and chemical giant tries to avoid potentially billions of dollars in damages.

The justices turned away a Bayer appeal and left in place a lower court decision upholding an $87 million judgment awarded in a lawsuit in California to Alberta and Alva Pilliod, who were diagnosed with cancer after spraying Roundup for more than three decades. The Supreme Court on June 21 rejected a Bayer appeal in a different Roundup case.

Bayer has argued that the cancer claims over Roundup and its active ingredient glyphosate go against sound science and product clearance from the U.S. Environmental Protection Agency. Bayer's appeal in the Pilliod case raised an additional challenge, arguing that it would violate the U.S. Constitution's due process protections to award punitive damages that far outweigh compensatory damages.

Alva and Alberta Pilliod both were diagnosed with non-Hodgkin's lymphoma, a type of lymph cancer, after decades of using Roundup. A California judge in 2020 reduced the $2 billion jury award in the case to $87 million. California's top court last year ruled against Bayer's appeal of the $87 million award.

Bayer, which also makes aspirin, Yasmin birth-control pills and the stroke prevention drug Xarelto among other products, has lost three trials in which Roundup users have been awarded tens of millions of dollars in each, while also winning four trials. Bayer pinned hopes for relief on the conservative-majority Supreme Court, which has a reputation for being pro-business.

Bayer said in its March annual report that it had resolved about 107,000 cases out of about 138,000 cases overall.

One of Bayer's core defenses in the litigation is that the EPA has decided glyphosate is not carcinogenic and not a risk to public health.

On June 17, a U.S. appeals court ordered the EPA to take a fresh look at whether glyphosate poses unreasonable risks to humans and the environment. The San Francisco-based 9th U.S. Circuit Court of Appeals agreed with several environmental, farm worker and food safety advocacy groups that the EPA did not adequately consider whether glyphosate causes cancer and threatens endangered species.

The EPA is scheduled to conclude that new review of glyphosate safety by Oct. 1.

Bayer has said it should not be penalized for marketing a product deemed safe by the EPA and on which the agency would not allow a cancer warning to be printed.

The lawsuits against Bayer have said the company should have warned customers of the alleged cancer risk.

Roundup-related lawsuits have dogged Bayer since it acquired the brand as part of its $63 billion purchase of agricultural seeds and pesticides maker Monsanto (NYSE:MON) in 2018.

In July 2021, Bayer took an additional litigation provision of $4.5 billion in case of an unfavorable ruling by the Supreme Court or in case the justices declined to consider its appeal. This leaves "significant upside" if the Supreme Court rules in its favor, according to Bayer.

The provision came on top of $11.6 billion it previously set aside for settlements and litigation over the matter.

Bayer plans to replace glyphosate in weedkillers for the U.S. residential market for non-professional gardeners. But it will continue to sell glyphosate-based weedkillers to farmers, who rely on it heavily and who according to Bayer have a negligible role in the litigation.

The appeal rejected by the justices on June 21 involved $25 million damages awarded in a separate lawsuit to California resident Edwin Hardeman, a Roundup user who blamed his cancer on the weedkillers.

U.S. Supreme Court again nixes Bayer challenge to weedkiller suits
 

Related Articles

SoftBank steps up asset sales from sinking portfolio
SoftBank steps up asset sales from sinking portfolio By Reuters - Aug 09, 2022

By Sam Nussey TOKYO (Reuters) - SoftBank Group Corp is accelerating asset sales after its flagship Vision Fund unit booked nearly $50 billion in losses in just six months, but...

Twitter Users Face Outage On Website and App
Twitter Users Face Outage On Website and App By Benzinga - Aug 09, 2022

Twitter Inc 's (NYSE: NYSE:TWTR) website is down for thousands of users, according to the real-time problem and outage monitor Downdetector.com. About 46% of website users...

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email